Breaking News Instant updates and real-time market news.

2020-12-01 10:46:17 SU Suncor $16.57 / +0.485 (+3.02%) 10:46 12/01/20 12/01 10:46 12/01/20 10:46	Suncor price target raised to C$22 from C$21 at National Bank National Bank analyst Travis Wood raised the firm's price target on Suncor to C$22 from C$21 and keeps a Sector Perform rating on the shares.
SU Suncor $16.57 / +0.485 (+3.02%) 12/01/20 TD Securities Suncor price target raised to C$27 from C$26 at TD Securities 11/02/20 Goldman Sachs Imperial Oil downgraded to Sell from Neutral at Goldman Sachs 10/29/20 BMO Capital Suncor price target lowered to C$25 from C$28 at BMO Capital 10/28/20 Citi Suncor downgraded to Neutral from Buy at Citi

2020-12-01 10:46:17

Suncor

$16.57 / +0.485 (+3.02%)

10:46

12/01/20

12/01

10:46

12/01/20

10:46

Suncor price target raised to C$22 from C$21 at National Bank

National Bank analyst Travis Wood raised the firm's price target on Suncor to C$22 from C$21 and keeps a Sector Perform rating on the shares.

SU Suncor

$16.57 / +0.485 (+3.02%)

12/01/20 TD Securities: Suncor price target raised to C$27 from C$26 at TD Securities

11/02/20 Goldman Sachs: Imperial Oil downgraded to Sell from Neutral at Goldman Sachs

10/29/20 BMO Capital: Suncor price target lowered to C$25 from C$28 at BMO Capital

10/28/20 Citi: Suncor downgraded to Neutral from Buy at Citi

TODAY'S FREE FLY STORIES

Initiation	MasterCard reinitiated with an Outperform at Bernstein » 06:17 01/27/21 01/27 06:17 01/27/21 06:17 MA MasterCard $327.71 / -1.565 (-0.48%) Bernstein analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MA MasterCard $327.71 / -1.565 (-0.48%) 01/13/21 Walgreens expands financial services in pact with Synchrony, Mastercard 12/14/20 Chase, Air Canada, MasterCard to launch U.S. credit card 12/08/20 MasterCard announces new $6B share buyback program 12/08/20 MasterCard raises quarterly dividend to 44c from 40c pe share MA MasterCard $327.71 / -1.565 (-0.48%) 01/26/21 KeyBanc MasterCard downgraded to Sector Weight from Overweight at KeyBanc 01/25/21 Barclays MasterCard price target raised to $380 from $360 at Barclays 01/14/21 Deutsche Bank MasterCard price target raised to $420 from $383 at Deutsche Bank 01/13/21 Fly Intel: Top five analyst upgrades MA MasterCard $327.71 / -1.565 (-0.48%) 01/25/21 Fly Intel: What to watch in credit card space earnings reports 10/28/20 MasterCard reports Q3 adjusted EPS $1.60, consensus $1.66 10/27/20 Notable companies reporting before tomorrow's open 10/27/20 Notable companies reporting before tomorrow's open MA MasterCard $327.71 / -1.565 (-0.48%) 12/27/20 MasterCard report says U.S. holiday retail sales up 3%, Reuters reports 12/21/20 Mary Meeker's Bond invests in Ironclad at $1B valuation, The Information says 09/08/20 Mastercard helping Asian central banks set up mobile payments, Bloomberg says 08/20/20 DOJ antitrust chief Delrahim orders restructuring to focus enforcement, WSJ says MA MasterCard $327.71 / -1.565 (-0.48%) 01/13/21 Tesla initiation, Home Depot upgrade among today's top calls on Wall Street 12/07/20 Lyft upgrade, McDonald's downgrade among today's top calls on Wall Street 10/28/20 Fly Intel: Pre-market Movers 07/30/20 Fly Intel: Wall Street's top stories for Thursday 01/28/21 MasterCard - MA MA MasterCard $327.71 / -1.565 (-0.48%) 01/14/21 Mastercard call volume above normal and directionally bullish 12/29/20 Mastercard call volume above normal and directionally bullish 12/24/20 Early notable gainers among liquid option names on December 24th 10/28/20 Unusually active option classes on open October 28th
Recommendations	Darden price target raised to $135 from $123 at Piper Sandler » 06:17 01/27/21 01/27 06:17 01/27/21 06:17 DRI Darden $118.54 / -1.59 (-1.32%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options DRI Darden $118.54 / -1.59 (-1.32%) 12/23/20 Darden VP Douglas Milanes sells almost $1.3M in company shares 12/18/20 Darden CEO says delivered 'strong profitability' in 'unpredictable environment' 12/18/20 Darden backs FY outlook for 35-40 net new restaurants 12/18/20 Darden elects CEO Eugene Lee, Jr. as Chairman of Board, succeeding Sonsteby DRI Darden $118.54 / -1.59 (-1.32%) 01/25/21 JPMorgan Darden price target raised to $130 from $122 at JPMorgan 01/19/21 Morgan Stanley Morgan Stanley upgrades Darden to Overweight on potential for dining out surge 01/19/21 Morgan Stanley Darden upgraded to Overweight from Equal Weight at Morgan Stanley 01/19/21 Goldman Sachs Darden initiated with a Buy at Goldman Sachs DRI Darden $118.54 / -1.59 (-1.32%) 12/18/20 Darden sees Q3 EPS 50c-75c, consensus $1.34 12/18/20 Darden reports Q2 diluted EPS 74c, consensus 71c 12/17/20 Notable companies reporting before tomorrow's open 12/17/20 Notable companies reporting before tomorrow's open 21 Apr DRI Darden $118.54 / -1.59 (-1.32%) 12/28/20 Fly Insider:180 Degree Capital, AMC among week's notable insider trades 12/18/20 Fly Intel: Pre-market Movers 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 11/23/20 Gap upgrade, Foot Locker downgrade among today's top calls on Wall Street DRI Darden $118.54 / -1.59 (-1.32%) 12/01/20 Largest borrow rate increases among liquid names 09/29/20 Darden put volume heavy and directionally bearish 09/25/20 Darden put volume heavy and directionally bearish 09/24/20 Early notable gainers among liquid option names on September 24th
Recommendations	Zimmer Biomet price target raised to $180 from $165 at JMP Securities » 06:17 01/27/21 01/27 06:17 01/27/21 06:17 ZBH Zimmer Biomet $158.18 / -1.16 (-0.73%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ZBH Zimmer Biomet $158.18 / -1.16 (-0.73%) 01/19/21 Zimmer Biomet appoints Ellison Humphrey as Chief Transformation Officer 12/07/20 Walgreens Boots Alliance names Pamela Puryear as Chief Human Resources Officer 08/04/20 Zimmer Biomet saw incremental improvement in May, June ZBH Zimmer Biomet $158.18 / -1.16 (-0.73%) 01/25/21 BTIG Zimmer Biomet price target raised to $173 from $160 at BTIG 01/08/21 Piper Sandler Zimmer Biomet price target raised to $185 from $160 at Piper Sandler 01/06/21 Truist Zimmer Biomet price target raised to $174 from $152 at Truist 01/04/21 Evercore ISI Zimmer Biomet upgraded to Outperform from In Line at Evercore ISI ZBH Zimmer Biomet $158.18 / -1.16 (-0.73%) 11/06/20 Zimmer Biomet not providing Q4 guidance 11/06/20 Zimmer Biomet reports Q3 adjusted EPS $1.81, consensus $1.07 08/04/20 Zimmer Biomet not providing FY20 guidance due to COVID-19 08/04/20 Zimmer Biomet reports Q2 adj. EPS 5c, consensus (73c) 02/05/21 Zimmer Biomet - ZBH ZBH Zimmer Biomet $158.18 / -1.16 (-0.73%) 12/29/20 Early notable gainers among liquid option names on December 29th
Downgrade	Burlington Stores downgraded to Neutral from Buy at Citi » 06:16 01/27/21 01/27 06:16 01/27/21 06:16 BURL Burlington Stores $251.14 / -1.39 (-0.55%) Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BURL Burlington Stores $251.14 / -1.39 (-0.55%) 11/24/20 Burlington Stores lowers FY20 CapEx view to $245M from $400M 08/27/20 Burlington Stores CEO sees 'a lot of risk in Q3' 08/27/20 Burlington Stores reports Q2 gross margin 45.8% vs. 41.4% last year 08/27/20 Burlington Stores backs FY20 CapEx view approximately $260M BURL Burlington Stores $251.14 / -1.39 (-0.55%) 01/22/21 Loop Capital Burlington Stores price target raised to $290 from $255 at Loop Capital 01/21/21 Deutsche Bank Burlington Stores price target raised to $279 from $246 at Deutsche Bank 01/04/21 JPMorgan Burlington Stores price target raised to $254 from $224 at JPMorgan 12/22/20 Wells Fargo Burlington Stores price target raised to $265 from $250 at Wells Fargo BURL Burlington Stores $251.14 / -1.39 (-0.55%) 11/24/20 Burlington Stores reports Q3 non-GAAP EPS 29c, consensus 16c 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open 08/27/20 Burlington Stores says FY20 guidance remains suspended BURL Burlington Stores $251.14 / -1.39 (-0.55%) 11/24/20 Fly Intel: Pre-market Movers 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 10/28/20 AMD, Lululemon upgrades among today's top calls on Wall Street 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street BURL Burlington Stores $251.14 / -1.39 (-0.55%) 10/09/20 Unusual call flow in option market yesterday 10/08/20 Call spread in Burlington Stores rolls two week 300% winner
Initiation	Fate Therapeutics assumed with a Neutral at H.C. Wainwright » 06:16 01/27/21 01/27 06:16 01/27/21 06:16 FATE Fate Therapeutics $89.07 / -7.08 (-7.36%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly FATE Fate Therapeutics $89.07 / -7.08 (-7.36%) 12/06/20 Fate presents patient case study from Phase 1 clinical trial of FT596 12/04/20 Fate Therapeutics reports 'positive' ph1 trial data for FT516 in B-cell lymphoma 11/16/20 Fate Therapeutics director sells 25K shares of common stock 08/19/20 Fate Therapeutics appoints Edward Dulac as CFO FATE Fate Therapeutics $89.07 / -7.08 (-7.36%) 01/25/21 BMO Capital Fate Therapeutics price target raised to $88 from $57 at BMO Capital 01/19/21 Oppenheimer Fate Therapeutics price target raised to $135 from $70 at Oppenheimer 01/15/21 Barclays Fate Therapeutics price target raised to $130 from $110 at Barclays 12/21/20 Stifel Fate Therapeutics price target raised to $118 from $79 at Stifel FATE Fate Therapeutics $89.07 / -7.08 (-7.36%) 11/05/20 Fate Therapeutics reports Q3 EPS (40c), consensus (36c) 08/05/20 Fate Therapeutics reports Q2 EPS (35c), consensus (27c) 06 Jan 09 Jun FATE Fate Therapeutics $89.07 / -7.08 (-7.36%) 01/04/21 Fly Intel: After-Hours Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 12/07/20 Crispr rises following ASH update for genome editing cell therapy candidate 12/07/20 Fly Intel: Wall Street's top stories at midday

Initiation	Visa reinitiated with an Outperform at Bernstein » 06:15 01/27/21 01/27 06:15 01/27/21 06:15 V Visa $202.01 / +1.03 (+0.51%) Bernstein analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options V Visa $202.01 / +1.03 (+0.51%) 01/22/21 MoneyGram expands Visa debit card deposit service across Europe 01/12/21 Visa, Plaid announce mutual termination of merger pact 01/11/21 Visa names Kelly Mahon chief legal and administrative officer 12/03/20 Visa taps Publicis, Wieden+Kennedy for global creative work V Visa $202.01 / +1.03 (+0.51%) 01/26/21 KeyBanc Visa downgraded to Sector Weight from Overweight at KeyBanc 01/26/21 Bernstein Visa reinstated with an Outperform at Bernstein 01/14/21 Deutsche Bank Visa price target raised to $270 from $220 at Deutsche Bank 01/13/21 Fly Intel: Top five analyst upgrades V Visa $202.01 / +1.03 (+0.51%) 01/25/21 Fly Intel: What to watch in credit card space earnings reports 11/02/20 Fly Intel: What to watch in PayPal earnings report 10/28/20 Visa reports Q4 payments volume up 4% on constant-dollar basis 10/28/20 Visa reports Q4 EPS $1.12, consensus $1.10 13 Oct V Visa $202.01 / +1.03 (+0.51%) 01/12/21 Visa temporarily halts all political contributions, Reuters reports 12/03/20 Visa picks Wieden+Kennedy, Publics after dropping BBDO, AdAge says 11/05/20 U.S. suing Visa to block acquisition of Plaid, Reuters reports 11/05/20 DOJ files lawsuit challenging Visa deal to acquire Plaid, WSJ reports V Visa $202.01 / +1.03 (+0.51%) 01/13/21 Tesla initiation, Home Depot upgrade among today's top calls on Wall Street 12/07/20 Lyft upgrade, McDonald's downgrade among today's top calls on Wall Street 12/04/20 The Intersection: Crypto and Wall Street This Week 11/05/20 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Technology & Internet Virtual Conference 01/28/21 Visa - V 02/11/21 Visa - V V Visa $202.01 / +1.03 (+0.51%) 12/29/20 Unusually active option classes on open December 29th 12/01/20 Visa call buyer realizes 4% same-day gains 11/24/20 Visa call volume above normal and directionally bullish 11/09/20 Visa call volume above normal and directionally bullish
Downgrade	GasLog downgraded to In Line from Outperform at Evercore ISI » 06:14 01/27/21 01/27 06:14 01/27/21 06:14 GLOG GasLog $4.17 / -0.375 (-8.25%) Evercore ISI analyst Sean… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GLOG GasLog $4.17 / -0.375 (-8.25%) 01/26/21 GasLog Partners director Robert Allardice resigns 01/20/21 GasLog falls -8.4% 01/20/21 GasLog falls -7.1% 09/17/20 GasLog appoints Kristin Golth to board of directors GLOG GasLog $4.17 / -0.375 (-8.25%) 09/01/20 DNB Markets GasLog upgraded to Buy from Hold at DNB Markets 06/23/20 Fearnley GasLog downgraded to Hold from Buy at Fearnley 06/02/20 Pareto GasLog downgraded to Sell from Hold at Pareto 03/31/20 Pareto GasLog upgraded to Hold from Sell at Pareto GLOG GasLog $4.17 / -0.375 (-8.25%) 08/05/20 GasLog reports Q2 EPS 3c, consensus 0c
Recommendations	Teleflex price target raised to $440 from $375 at JMP Securities » 06:14 01/27/21 01/27 06:14 01/27/21 06:14 TFX Teleflex $383.21 / +0.84 (+0.22%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TFX Teleflex $383.21 / +0.84 (+0.22%) 01/20/21 Teleflex: Data show sexual function improvement with UroLift System 10/28/20 Teleflex to acquire Z-Medica 10/01/20 Teleflex announces expanded indications for Arrow EZ-IO System 08/03/20 FDA posts 510(k) premarket approval of Teleflex Urolift 2 System TFX Teleflex $383.21 / +0.84 (+0.22%) 01/11/21 Wells Fargo Teleflex price target raised to $455 from $425 at Wells Fargo 01/06/21 Needham Teleflex price target raised to $445 from $406 at Needham 12/15/20 SVB Leerink Teleflex price target raised to $450 from $415 at SVB Leerink 12/15/20 UBS Teleflex price target raised to $455 from $435 at UBS TFX Teleflex $383.21 / +0.84 (+0.22%) 10/29/20 Teleflex not reinstating FY20 guidance due to COVID-19 pandemic 10/29/20 Teleflex reports Q3 adjusted EPS $2.77, consensus $2.24 07/30/20 Teleflex not reinstating FY20 guidance due to COVID-19 pandemic 07/30/20 Teleflex reports Q2 adjusted EPS $1.93, consensus $1.25
Downgrade	Ulta Beauty downgraded to Neutral from Buy at Citi » 06:14 01/27/21 01/27 06:14 01/27/21 06:14 ULTA Ulta Beauty $295.77 / +0.03 (+0.01%) Citi analyst Kelly Crago… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ULTA Ulta Beauty $295.77 / +0.03 (+0.01%) 12/04/20 Ulta Beauty seeing innovation across 'every single category,' CEO says 12/03/20 Ulta Beauty sees Q4 SSS down 12%-14% 12/03/20 Ulta Beauty reports Q3 SSS down 8.9% 12/03/20 Ulta Beauty drops 6% to $272.00 after Q3 results ULTA Ulta Beauty $295.77 / +0.03 (+0.01%) 01/21/21 Wells Fargo Ulta Beauty price target raised to $330 from $320 at Wells Fargo 01/11/21 Cleveland Research Ulta Beauty Q4-to-date comps appear ahead of consensus, says Cleveland Research 12/17/20 DA Davidson Ulta Beauty comp acceleration seen 'among the best', says DA Davidson 12/14/20 JPMorgan Ulta Beauty added to Analyst Focus List at JPMorgan ULTA Ulta Beauty $295.77 / +0.03 (+0.01%) 12/03/20 Ulta Beauty reports Q3 EPS $1.64, consensus $1.49 12/03/20 Notable companies reporting after market close 08/27/20 Ulta Beauty reports Q2 EPS 73c, consensus 6c 08/27/20 Notable companies reporting after market close ULTA Ulta Beauty $295.77 / +0.03 (+0.01%) 10/12/20 Ulta Beauty speculated as possible activist target by Activist Insights ULTA Ulta Beauty $295.77 / +0.03 (+0.01%) 12/04/20 Fly Intel: Wall Street's top stories for Friday 12/04/20 Fly Intel: Wall Street's top stories at midday 12/04/20 Fly Intel: Pre-market Movers 12/03/20 Fly Intel: After-Hours Movers 03/11/21 Ulta Beauty - ULTA ULTA Ulta Beauty $295.77 / +0.03 (+0.01%) 12/03/20 Ulta Beauty options imply 10.1% move in share price post-earnings 11/10/20 Early notable gainers among liquid option names on November 10th 11/10/20 Unusually active option classes on open November 10th 08/28/20 Early notable gainers among liquid option names on August 28th
Recommendations	Steven Madden price target raised to $35 from $29 at Citi » 06:13 01/27/21 01/27 06:13 01/27/21 06:13 SHOO Steven Madden / + Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SHOO Steven Madden / + 12/10/20 Steven Madden appoints Zine Mazouzi as CFO effective January 1 10/27/20 Steven Madden not providing guidance SHOO Steven Madden / + 12/10/20 B. Riley Securities Steven Madden price target raised to $40 from $34 at B. Riley Securities 12/09/20 Loop Capital Steven Madden price target raised to $35 from $25 at Loop Capital 12/09/20 Susquehanna Steven Madden price target raised to $41 from $30 at Susquehanna 12/08/20 Jefferies Deckers Brands price target raised to $346 from $315 at Jefferies SHOO Steven Madden / + 10/27/20 Steven Madden reports Q3 adjusted EPS 39c, consensus 21c 07/29/20 Steven Madden not providing guidance at this time 07/29/20 Steven Madden reports Q2 adjusted EPS (19c), consensus (27c)

Upgrade	Texas Instruments upgraded to Buy from Hold at Summit Insights » 06:13 01/27/21 01/27 06:13 01/27/21 06:13 TXN Texas Instruments / + Summit Insights upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TXN Texas Instruments / + 01/26/21 Texas Instruments sees 2021 annual operating tax rate ~14% 01/26/21 Texas Instruments CEO says Q4 revenue driven by strong demand in automotive 12/09/20 Texas Instruments: Most of HiRel semiconductor products now available online 11/18/20 Xilinx works with Texas Instruments to develop DFE radio application solutions TXN Texas Instruments / + 01/26/21 Barclays Texas Instruments price target raised to $155 from $140 at Barclays 01/21/21 Oppenheimer Texas Instruments price target raised to $185 from $180 at Oppenheimer 01/21/21 Oppenheimer Texas Instruments price target raised to $185 from $180 at Oppenheimer 12/17/20 Deutsche Bank Texas Instruments price target raised to $150 from $145 at Deutsche Bank TXN Texas Instruments / + 01/26/21 Texas Instruments sees Q1 EPS $1.44-$1.66 , consensus $1.34 01/26/21 Texas Instruments reports Q4 EPS $1.80, consensus $1.34 01/26/21 Notable companies reporting after market close 10/20/20 Texas Instruments sees Q4 EPS $1.20-$1.40, consensus $1.19 TXN Texas Instruments / + 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says 08/22/20 'Underappreciated' Synaptics shares have more upside, Barron's says 08/13/20 Intel unveils transistor technology to boost chip performance, Reuters says TXN Texas Instruments / + 01/26/21 Fly Intel: After-Hours Movers 10/20/20 Fly Intel: After-Hours Movers TXN Texas Instruments / + 01/26/21 Texas Instruments options imply 6.5% move in share price post-earnings 12/28/20 Texas Instruments put volume heavy and directionally bearish 12/21/20 Texas Instruments put volume heavy and directionally bearish 11/10/20 Texas Instruments put volume heavy and directionally bearish
Recommendations	Levi Strauss price target raised to $25 from $19 at Citi » 06:12 01/27/21 01/27 06:12 01/27/21 06:12 LEVI Levi Strauss $21.35 / +0.13 (+0.61%) Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options LEVI Levi Strauss $21.35 / +0.13 (+0.61%) 01/26/21 Target, Levi Strauss expand partnership with limited-edition collection 10/07/20 Levi Strauss CEO: Denim is still bigger than athleisure 10/07/20 Levi Strauss rises 12.6% 10/06/20 Levi Strauss surged 11.4% after upbeat Q3 results LEVI Levi Strauss $21.35 / +0.13 (+0.61%) 01/07/21 JPMorgan Levi Strauss price target raised to $21 from $18 at JPMorgan 12/30/20 Guggenheim Levi Strauss price target raised to $24 from $20 at Guggenheim 12/10/20 Fly Intel: Top five analyst upgrades 12/10/20 Goldman Sachs Levi Strauss upgraded to Buy from Sell at Goldman Sachs LEVI Levi Strauss $21.35 / +0.13 (+0.61%) 10/06/20 Levi Strauss reports Q3 adjusted EPS 8c, consensus (22c) LEVI Levi Strauss $21.35 / +0.13 (+0.61%) 12/10/20 Fly Intel: Pre-market Movers 10/07/20 Fly Intel: Wall Street's top stories for Wednesday 10/07/20 Fly Intel: Wall Street's top stories at midday 10/07/20 Fly Intel: Pre-market Movers 17:00 Today Levi Strauss - LEVI LEVI Levi Strauss $21.35 / +0.13 (+0.61%) 10/06/20 Levi Strauss options imply 11.1% move in share price post-earnings
Recommendations	Neuronetics price target raised to $23 from $15 at JMP Securities » 06:12 01/27/21 01/27 06:12 01/27/21 06:12 STIM Neuronetics $18.81 / -0.79 (-4.03%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options STIM Neuronetics $18.81 / -0.79 (-4.03%) 01/19/21 Neuronetics' depression disorder registry reaches 10,000 patients 01/07/21 Neuronetics announces expansion of sales organization 11/23/20 FDA grants clearance for Neuronetics' TouchStar treatment 11/23/20 Neuronetics receives FDA 510k clearance for NeuroStar Advanced Therapy device STIM Neuronetics $18.81 / -0.79 (-4.03%) 01/22/21 William Blair Neuronetics upgraded to Outperform from Market Perform at William Blair 01/21/21 BTIG Neuronetics price target raised to $21 from $14 at BTIG 01/21/21 Piper Sandler Neuronetics price target raised to $27 from $20 at Piper Sandler 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler STIM Neuronetics $18.81 / -0.79 (-4.03%) 01/12/21 Neuronetics sees FY20 revenue $48.7M-$49.2M, consensus $46.95M 01/12/21 Neuronetics sees Q4 revenue $15M-$15.5M, consensus $13.26M 08/04/20 Neuronetics reports Q2 EPS (41c), consensus (51c) STIM Neuronetics $18.81 / -0.79 (-4.03%) 01/12/21 Fly Intel: After-Hours Movers 11/23/20 Fly Intel: After-Hours Movers STIM Neuronetics $18.81 / -0.79 (-4.03%) 09/30/20 Thirteen new option listings and two option delistings on September 30th
Hot Stocks	Amdocs' Optima selected by Windtre in Italy for monetization platform » 06:12 01/27/21 01/27 06:12 01/27/21 06:12 DOX Amdocs $71.52 / -0.09 (-0.13%) Amdocs announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events DOX Amdocs $71.52 / -0.09 (-0.13%) 01/13/21 Amdocs expands agreement with Capita 01/06/21 Amdocs' software solutions selected by ICE Norway for 4G & 5G network expansion 12/07/20 Amdocs, Vodafone Romania partner on Digital Experience platform 12/01/20 Amdocs and Telefonica Movistar Chile extend and expand partnership DOX Amdocs $71.52 / -0.09 (-0.13%) 11/11/20 JPMorgan Amdocs upgraded to Overweight with $75 target at JPMorgan 11/11/20 JPMorgan Amdocs upgraded to Overweight from Neutral at JPMorgan 02/05/20 Oppenheimer Amdocs price target raised to $85 from $77 at Oppenheimer DOX Amdocs $71.52 / -0.09 (-0.13%) 11/10/20 Amdocs sees FY21 revenue growth of 3.5%-7.5% YoY, consensus $4.28B 11/10/20 Amdocs sees FY21 EPS growth approximately 5%-9% YoY 11/10/20 Amdocs sees Q1 EPS 1.09-$1.15, consensus $1.14 11/10/20 Amdocs reports Q4 EPS $1.23, consensus $1.18 DOX Amdocs $71.52 / -0.09 (-0.13%) 11/10/20 Fly Intel: After-Hours Movers 02/02/21 Amdocs - DOX
Recommendations	Integra LifeSciences price target raised to $80 from $65 at JMP Securities » 06:11 01/27/21 01/27 06:11 01/27/21 06:11 IART Integra LifeSciences $69.91 / +0.52 (+0.75%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events IART Integra LifeSciences $69.91 / +0.52 (+0.75%) 01/20/21 Integra LifeSciences completes acquisition of ACell 01/04/21 Integra LifeSciences completes sale of Extremity Orthopedics unit to Smith & Nephew 12/16/20 Integra LifeSciences to acquire ACell for upfront payment of $300M 11/03/20 InspireMD appoints Andrea Tommasoli as SVP, global sales and marketing IART Integra LifeSciences $69.91 / +0.52 (+0.75%) 01/19/21 BTIG Integra LifeSciences price target raised to $72 from $66 at BTIG 01/07/21 Credit Suisse Integra LifeSciences price target raised to $73 from $60 at Credit Suisse 01/06/21 Truist Integra LifeSciences price target raised to $70 from $60 at Truist 12/17/20 Oppenheimer Integra LifeSciences price target raised to $72 from $64 at Oppenheimer IART Integra LifeSciences $69.91 / +0.52 (+0.75%) 01/14/21 Integra LifeSciences sees FY20 reported revenue $1.37B-$1.372B 01/14/21 Integra LifeSciences sees Q4 revenue $387M-$389M, consensus $389.05M 10/28/20 Integra LifeSciences sees 'further sequential revenue improvement' in Q4 10/28/20 Integra LifeSciences says FY20 guidance remains withdrawn IART Integra LifeSciences $69.91 / +0.52 (+0.75%) 10/06/20 Fly Intel: After-Hours Movers 08/10/20 Fly Intel: After-Hours Movers 02/18/21 Integra LifeSciences - IART

Periodicals	Ant Group plans sale of EyeVerify amid user data scrutiny, FT reports » 06:10 01/27/21 01/27 06:10 01/27/21 06:10 BABA Alibaba $265.91 / +4.45 (+1.70%) Ant Group plans to sell… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BABA Alibaba $265.91 / +4.45 (+1.70%) 01/20/21 Best Inc up 12% in pre-market, considering sale as part of its strategic review 01/08/21 Bill Miller sees little impact on Alibaba cash flow from regulation 01/08/21 Alibaba recent pullback offers buying opportunity, Bill Miller says 01/08/21 Alibaba, Tencent not on Treasury's updated 'Chinese Military Companies' list BABA Alibaba $265.91 / +4.45 (+1.70%) 01/26/21 KeyBanc Pinduoduo downgraded to Sector Weight at KeyBanc on balanced risk/reward 01/26/21 Deutsche Bank Alibaba price target lowered to $319 from $360 at Deutsche Bank 01/25/21 Fly Intel: Top five analyst initiations 01/25/21 Bernstein Alibaba initiated with a Market Perform at Bernstein BABA Alibaba $265.91 / +4.45 (+1.70%) 11/05/20 Alibaba reports Q2 adjusted EPS $2.65, consensus $2.11 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open 08/20/20 Alibaba reports Q1 adjusted EPS $2.10, consensus $1.99 BABA Alibaba $265.91 / +4.45 (+1.70%) 01/22/21 PBoC drafts rules that will hurt Alibaba affiliate Ant Group, FT reports 01/20/21 Alibaba's Jack Ma makes first appearance since criticizing China, NYT says 01/13/21 Americans to still be able to invest in Chinese tech giants, WSJ reports 01/07/21 Ant Group plans to restructure consumer credit operations, Bloomberg reports BABA Alibaba $265.91 / +4.45 (+1.70%) 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 01/09/21 Week in review: How Trump's policies moved stocks 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 12/28/20 Fly Intel: Wall Street's top stories for Monday 02/02/21 Alibaba - BABA BABA Alibaba $265.91 / +4.45 (+1.70%) 01/08/21 Notable open interest changes for January 8th 12/31/20 Notable open interest changes for December 31st 12/30/20 Unusually active option classes on open December 30th 12/30/20 Notable open interest changes for December 30th
Upgrade	Himax upgraded to Buy from Neutral at Nomura » 06:10 01/27/21 01/27 06:10 01/27/21 06:10 HIMX Himax $9.75 / +0.95 (+10.80%) Nomura upgraded Himax to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options HIMX Himax $9.75 / +0.95 (+10.80%) 11/30/20 Baird Himax price target raised to $11 from $8 at Baird 05/08/20 Lake Street Himax challenges not due to change in competitive position, says Lake Street 04/01/20 Lake Street Lake Street confident Himax positioned to see continued momentum 03/25/20 Baird Himax emerging from transition, re- initiated with an Outperform at Baird HIMX Himax $9.75 / +0.95 (+10.80%) 01/07/21 Himax reports preliminary Q4 adjusted EPS 19.7c, consensus 15c 11/12/20 Himax reports Q3 non-IFRS EPS 7.3c, consensus 3c 10/06/20 Himax reports preliminary Q3 non-IFRS EPS 7.3c, consensus 2c 08/06/20 Himax sees Q3 non-IFRS EPS 3.5c-4.3c, consensus (2c) HIMX Himax $9.75 / +0.95 (+10.80%) 11/12/20 Fly Intel: Pre-market Movers 10/06/20 Fly Intel: Pre-market Movers 02/04/21 Himax - HIMX HIMX Himax $9.75 / +0.95 (+10.80%) 01/06/21 Himax call volume above normal and directionally bullish
Recommendations	Capri Holdings price target raised to $53 from $32 at Citi » 06:10 01/27/21 01/27 06:10 01/27/21 06:10 CPRI Capri Holdings $42.44 / -0.79 (-1.83%) Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CPRI Capri Holdings $42.44 / -0.79 (-1.83%) 01/07/21 Capri Holdings to replace Enphase Energy in the S&P 400 at open on January 7 01/06/21 Celsius Holdings confirms addition to S&P SmallCap 600 Index, effective Jan. 7 12/30/20 Capri Holdings to replace Enphase Energy in the S&P 400 at open on January 7 11/05/20 Capri Holdings sees Q4 sales below prior year CPRI Capri Holdings $42.44 / -0.79 (-1.83%) 01/21/21 Deutsche Bank Capri Holdings upgraded to Buy from Hold at Deutsche Bank 01/21/21 Deutsche Bank Capri Holdings upgraded to Buy from Hold at Deutsche Bank 01/07/21 JPMorgan Capri Holdings price target raised to $43 from $34 at JPMorgan 01/07/21 Barclays Capri Holdings upgraded to Overweight from Equal Weight at Barclays CPRI Capri Holdings $42.44 / -0.79 (-1.83%) 11/05/20 Capri Holdings sees Q3 sales down double digits, consensus $1.27B 11/05/20 Capri Holdings sees FY sales down approximately 30%, consensus $3.79B 11/05/20 Capri Holdings not providing earnings guidance for FY21 11/05/20 Capri Holdings reports Q2 adjusted EPS 90c, consensus 4c CPRI Capri Holdings $42.44 / -0.79 (-1.83%) 10/26/20 Hedgeye adds Capri Holdings to best ideas list, Bloomberg says CPRI Capri Holdings $42.44 / -0.79 (-1.83%) 12/31/20 Fly Intel: Pre-market Movers 12/30/20 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street 02/03/21 Capri Holdings - CPRI CPRI Capri Holdings $42.44 / -0.79 (-1.83%) 01/07/21 Capri Holdings put volume heavy and directionally bearish 09/24/20 Capri Holdings call volume above normal and directionally bullish 09/15/20 Capri Holdings put volume heavy and directionally bearish 09/14/20 Capri Holdings call volume above normal and directionally bullish
Downgrade	SunPower downgraded to Neutral from Overweight at Piper Sandler » 06:10 01/27/21 01/27 06:10 01/27/21 06:10 SPWR SunPower / + Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SPWR SunPower / + 01/07/21 SunPower closing manufacturing facility in Hillsboro, Oregon 01/07/21 Hannon Armstrong announces leadership moves, promotes Jeffrey Lipson to COO 08/27/20 Total 'fully supports' SunPower spin-off of Maxeon Solar 08/27/20 SunPower, Maxeon Solar complete spin-off transaction SPWR SunPower / + 01/20/21 JPMorgan SunPower price target raised to $25 from $21 at JPMorgan 01/20/21 Credit Suisse SunPower price target raised to $23 from $16 at Credit Suisse 01/19/21 Piper Sandler SunPower price target raised to $35 from $22 at Piper Sandler 01/12/21 Fly Intel: Top five analyst initiations SPWR SunPower / + 10/28/20 SunPower raises 2020 non-GAAP revenue view to $1.12-$1.16B from $1.06B-$1.10B 10/28/20 SunPower still sees Q4 revenue $330M-$370M, consensus $350.28M 10/28/20 SunPower reports Q3 non-GAAP EPS (4c), consensus (5c) 10/28/20 Notable companies reporting after market close SPWR SunPower / + 11/11/20 Former Google exec seen as 'top' Biden energy pick, Bloomberg reports SPWR SunPower / + 01/16/21 Charged: NIO unveils new sedan, Plug partners with Renault 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 03/15/21 33rd Annual Roth Virtual Conference SPWR SunPower / + 01/22/21 SunPower call volume above normal and directionally bullish 01/14/21 SunPower call volume above normal and directionally bullish 11/04/20 Unusually active option classes on open November 4th 11/03/20 SunPower put volume heavy and directionally bearish
Downgrade	Navigator Holdings downgraded to In Line from Outperform at Evercore ISI » 06:09 01/27/21 01/27 06:09 01/27/21 06:09 NVGS Navigator Holdings / + Evercore ISI downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings NVGS Navigator Holdings / + 12/29/20 Navigator Holdings closes sale of 39.1% equity interest to BW Group 12/15/20 WL Ross & Co. to sell 39.1% interest in Navigator Holdings to BW Group NVGS Navigator Holdings / + 11/12/20 Navigator Holdings reports Q3 EPS 3c, consensus 9c 08/13/20 Navigator Holdings reports Q2 EPS 5c, consensus 0c

Upgrade	Liberty Oilfield Services upgraded to Outperform from In Line at Evercore ISI » 06:09 01/27/21 01/27 06:09 01/27/21 06:09 LBRT Liberty Oilfield Services / + Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events LBRT Liberty Oilfield Services / + 10/07/20 Liberty Oilfield Services falls -7.4% 10/07/20 Liberty Oilfield Services falls -7.2% 10/07/20 Liberty Oilfield Services falls -6.8% 09/01/20 Liberty Oilfield Services rises 36.0% LBRT Liberty Oilfield Services / + 01/11/21 Wolfe Research Liberty Oilfield Services downgraded to Underperform from Peer Perform at Wolfe Research 12/24/20 Piper Sandler Liberty Oilfield Services price target raised to $8 from $7.50 at Piper Sandler 12/15/20 Citi Liberty Oilfield Services price target raised to $12 from $7 at Citi 12/07/20 Liberty Oilfield Services cut to Equal Weight at Wells Fargo following run-up LBRT Liberty Oilfield Services / + 10/27/20 Liberty Oilfield Services reports Q3 EPS (41c), consensus (42c) 07/28/20 Liberty Oilfield Services reports Q2 adjusted EPS (55c), consensus (44c) 07 Oct LBRT Liberty Oilfield Services / + 09/01/20 Fly Intel: Wall Street's top stories for Tuesday 09/01/20 Fly Intel: Wall Street's top stories at midday 02/05/21 Liberty Oilfield Services - LBRT
Earnings	Southside Bancshares reports Q4 EPS 89c, consensus 64c » 06:09 01/27/21 01/27 06:09 01/27/21 06:09 SBSI Southside Bancshares $32.92 / -0.29 (-0.87%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SBSI Southside Bancshares $32.92 / -0.29 (-0.87%) 11/16/20 Southside Bancshares resumes stock repurchase plan 11/10/20 Southside Bancshares raises quarterly dividend to 32c, declares special dividend SBSI Southside Bancshares $32.92 / -0.29 (-0.87%) 12/15/20 Truist Truist raises price targets on select regional banks SBSI Southside Bancshares $32.92 / -0.29 (-0.87%) 10/23/20 Southside Bancshares reports Q3 EPS 82c, consensus 56c 10:00 Today Southside Bancshares - SBSI
Upgrade	NexTier Oilfield upgraded to Outperform from In Line at Evercore ISI » 06:09 01/27/21 01/27 06:09 01/27/21 06:09 NEX NexTier Oilfield / + Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NEX NexTier Oilfield / + 11/18/20 National Oilwell, NexTier Oilfield partner on field test of electric frac system 08/03/20 NexTier Oilfield sees FY20 CapEx $100M-$120M NEX NexTier Oilfield / + 12/24/20 Piper Sandler NexTier Oilfield price target raised to $4.10 from $3.25 at Piper Sandler 12/15/20 Citi NexTier Oilfield price target raised to $4 from $3 at Citi 10/13/20 BofA BofA cuts Liberty Oilfield to Neutral, sees outperformance to NexTier reversing 10/13/20 BofA NexTier Oilfield upgraded to Buy on completions recovery expectations at BofA NEX NexTier Oilfield / + 11/03/20 NexTier Oilfield sees Q4 revenue up 10%-15% sequentially 11/03/20 NexTier Oilfield reports Q3 adjusted EPS (38c), consensus (37c) 08/03/20 NexTier Oilfield reports Q2 adjusted EPS (37c), consensus (53c) 03/01/21 26th Annual Energy Virtual Summit 02/16/21 NexTier Oilfield - NEX
Recommendations	Deckers Brands price target raised to $380 from $310 at Citi » 06:09 01/27/21 01/27 06:09 01/27/21 06:09 DECK Deckers Brands / + Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events DECK Deckers Brands / + 07/28/20 Deckers Brands division, Cotopaxi collaborate on sustainable collection DECK Deckers Brands / + 01/22/21 Williams Capital Deckers Brands initiated with a Buy at Williams Trading 01/21/21 UBS Deckers Brands price target raised to $400 from $388 at UBS 01/13/21 BTIG Deckers Brands price target raised to $412 from $307 at BTIG 12/11/20 Raymond James Deckers Brands initiated with a Market Perform at Raymond James DECK Deckers Brands / + 10/29/20 Deckers Brands not providing full year guidance for fiscal year 2021 10/29/20 Deckers Brands reports Q2 EPS $3.58, consensus $2.63 07/30/20 Deckers Brands not providing full year guidance for fiscal year 2021 07/30/20 Deckers Brands reports Q1 EPS (28c), consensus ($1.11) DECK Deckers Brands / + 10/29/20 Fly Intel: After-Hours Movers 02/04/21 Deckers Brands - DECK
Downgrade	eGain downgraded to Hold from Buy at Berenberg » 06:09 01/27/21 01/27 06:09 01/27/21 06:09 EGAN eGain $11.81 / -0.21 (-1.75%) Berenberg analyst Brett… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EGAN eGain $11.81 / -0.21 (-1.75%) 09/14/20 eGain achieves FedRAMP "In Process" status 08/20/20 Omnichannel retailer offers expanded self-service with eGain 08/11/20 eGain CEO 'bullish' despite 'uncertain' short-term economic outlook EGAN eGain $11.81 / -0.21 (-1.75%) 01/14/21 Oppenheimer eGain downgraded to Perform at Oppenheimer on elevated execution risk 01/14/21 Oppenheimer eGain downgraded to Perform from Outperform at Oppenheimer 10/20/20 Berenberg eGain initiated with a Buy at Berenberg 10/14/20 Benchmark eGain share price may be benefiting from M&A speculation, says Benchmark EGAN eGain $11.81 / -0.21 (-1.75%) 11/10/20 eGain sees Q2 EPS (2c)-2c, consensus 6c 11/10/20 eGain reports Q3 EPS 8c, consensus 6c 09/02/20 eGain sees Q1 EPS 5c-8c, consensus 3c 09/02/20 eGain reports Q4 EPS 8c, consensus 5c EGAN eGain $11.81 / -0.21 (-1.75%) 01/14/21 Shopify, Intel upgrades among today's top calls on Wall Street 11/11/20 Fly Intel: Wall Street's top stories for Wednesday 11/11/20 Fly Intel: Wall Street's top stories at midday 11/11/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 1/22/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 1/22/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 1/22/2021 Government Event
CLS
Today at 08:00

Celestica - CLS Conference Calls
MPX
Today at 08:00

Marine Products - MPX Conference Calls
NDAQ
Today at 08:00

Nasdaq - NDAQ Conference Calls
NAVI
Today at 08:00

Navient - NAVI Conference Calls
TXT
Today at 08:00

Textron - TXT Conference Calls
Today at 08:30

Durable Goods New Orders M/M: December 2020 Government Event
Today at 08:30

Durable Goods Orders--Ex Transportation M/M: December 2020 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James $5.75-6.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities $14.00 - 14.50 4M Shares PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley $65.00-67.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen $38.00 - 40.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Suncor price target raised to C$22 from C$21 at National Bank

TODAY'S FREE FLY STORIES

Get Full Fly Access